Adverse Drug Events in Children: How Big is the Problem?

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|9|2|109-110

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.9, Iss.2, 2015-08, pp. : 109-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adverse drug events in outpatients

By  

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite

Detection of drug-related adverse events in hospitals

By Thürmann Petra A  

Expert Opinion on Drug Safety, Vol. 2, Iss. 5, 2003-09 ,pp. : 447-449

Informa Healthcare

Access to resources Recommend Favorite

Counting the Costs of Drug-Related Adverse Events

By White T.J.  

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 445-458

Adis International

Access to resources Recommend Favorite

Pharmacogenomics and reducing the frequency of adverse drug events

By O’Kane Dennis J   Weinshilboum Richard M   Moyer Thomas P  

Pharmacogenomics, Vol. 4, Iss. 1, 2003-01 ,pp. : 1-4

Future Medicine

Access to resources Recommend Favorite

Incidence, Preventability, and Impact of Adverse Drug Events (ADEs) and Potential ADEs in Hospitalized Children in New Zealand: A Prospective Observational Cohort Study

By Kunac Desireé L.  

Pediatric Drugs, Vol. 11, Iss. 2, 2009-01 ,pp. : 153-160

Adis International

Access to resources Recommend Favorite